New Cervical cancer diagnostic

New Cervical cancer diagnostic

The problem with advances in cancer is that they tend to show up the exaggerations of previous claims. And here we have it again: In the ‘world’s largest ever screening trial led by UCL,

The new method uses a statistical calculation to interpret changing levels in women’s blood of a protein called CA125, which is linked to ovarian cancer. This gives a more accurate prediction of a woman’s individual risk of developing cancer, compared to the conventional screening method, which uses a fixed ’cut-off’ point for CA125.

The new method detected cancer in 86% of unlike the current test which would have identified fewer than half of these women (41% or 48% respectively).
 

2015 Research
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.